CORONAVIRUS NEWS
Final speaker confirmed for BSMT Virtual Conference on COVID-19
The BSMT has confirmed that Professor Sheena Cruikshank (University of Manchester) will speak on 'From Variola to COVID-19: the Development of Modern Vaccines'. Click on this news item for the link to register for this FREE-to-attend webinar series.
Register now for the BSMT Virtual Conference on COVID-19
The British Society for Microbial Technology event takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for this FREE-to-attend webinar series.
Rapid antigen self-test selected by NIH for RADx initiative funding
Mologic, a developer of lateral-flow and rapid diagnostics, has announced its rapid antigen self-test for SARS-CoV-2 has been selected by the Rapid Acceleration of Diagnostics (RADx) initiative launched by the US National Institutes of Health (NIH).
Global distribution agreement for SARS-CoV-2 research ELISA reagents
Avacta Group, the developer of cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, has announced a global distribution agreement with ABCAM to sell the SARS-CoV-2 research ELISA Affimer reagents.
COVID-19: BSMT Virtual Conference in May – REGISTRATION now open
The BSMT Virtual Conference on COVID-19 is a FREE-to-attend event that takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for the webinar series.
Enhance COVID-19 diagnostic testing solution announced
Thermo Fisher Scientific and Artificial, a developer of flexible automation software, have announced a technology collaboration to develop an integrated and comprehensive software platform for Thermo Fisher’s standardised COVID-19 Testing Platform.
COVID-19: The Infection Challenging the World – BSMT sponsor update
This British Society for Microbial Technology (BSMT) virtual conference, held in conjunction with media partner Pathology in Practice, on 11–14 May, will be sponsored by 22 companies.
Novel SARS-CoV-2 neutralising antibodies identified
IONTAS and FairJourney Biologics have announced the identification of neutralising antibodies, which bind to multiple emerging SARS-CoV-2 variants.
Interleukin-6 test now available to help identify severe COVID-19
Beckman Coulter today has expanded claims for its CE-marked Access Interleukin-6 (IL-6) assay, an in vitro diagnostic test for the quantitative determination of IL-6 levels in human serum and plasma.
Commercial partnership to develop SARS-CoV-2 rapid antigen test
Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has announced a commercial partnership with Mologic, a developer and manufacturer of lateral-flow and rapid diagnostic tests.
COVID-19: The Infection Challenging the World – BSMT programme update
Additions to the programme and sponsors for this important British Society for Microbial Technology (BSMT) virtual conference, which will be held on 11–14 May, have now been released. See the following for the latest details…
A new face for the BSMT, and a virtual meeting in May
The British Society for Microbial Technology (BSMT) will hold a virtual conference entitled ‘COVID-19 – The Infection Challenging the World' over four days in May. Click on this story for current details of the programme and commercial support.
Rapid antigen test confirmed to detect SARS-CoV-2 new variants
Avacta Group has announced that the AffiDX SARS-CoV-2 rapid antigen lateral-flow test detects the dominant new variants of the coronavirus, known as the B117 (Kent), variant, and the D614G variant, as well as the original strain.
Convenient and rapid antigen nasal test launched in the UK
Roche Diagnostics has launched a rapid antigen nasal test in the UK, with millions of kits available immediately to help businesses and organisations looking to reopen as lockdown restrictions are lifted.
Detection of IgG antibodies against four SARS-CoV-2 antigens
Bio-Rad Laboratories has announced the launch of the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel.
Increasing laboratory efficiency in a remote environment: a webinar
The SARS-CoV-2 pandemic has resulted in a challenging work environment. This has made the development and commercialisation of vaccines, treatments and critically needed PCR-based and serological diagnostics especially challenging.
A milestone and investment in COVID-19 testing capacity
Randox has processed its 10-millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone, having invested £85 million since March 2020 in facilities and equipment.
Evaluation of SARS-CoV-2 lateral-flow test with clinical samples
Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK, which show excellent performance in identifying patients with an infectious viral load and no false positive results.
Antimicrobial resistance: a problem with disinfectants
South African scientists warn of grave danger that disinfectant use against SARS-CoV-2 could be helping bacteria to become resistant to disinfectants.
A need to reconfigure and an opportunity to transform
The in vitro diagnostics industry has been at the forefront of the fight against SARS-CoV-2 and medicine’s response to cases of severe COVID-19 disease.
Featured Supplier
Hamamatsu Photonics UK Limited is a world-leading manufacturer of optoelectronic components and systems. The Company's corporate philosophy stesses the advancement of photonics through extensve research and yields products that are regarded as state-of-the-art. Developments in digital imaging continue to be made by the Hamamatsu Systems Divison,...
Upcoming Events
COVID-19 - The Infection Challenging the World
Online
11-14 May 2021
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
